Description
Selank 10mg + Semax 10mg | Nootropic Research Peptide Blend
This blend pairs two synthetic heptapeptides originally developed by Russian research institutes: Selank, an analog of the immunomodulatory peptide tuftsin extended with a Pro-Gly-Pro tail, and Semax, an analog of the ACTH(4-10) fragment carrying the same stabilizing tail.
Selank has been characterized in models of GABAergic neurotransmission and enkephalin degradation, while Semax research has focused on brain-derived neurotrophic factor (BDNF) expression and attention and memory paradigms in laboratory animals. Together they are frequently paired in cognitive and neuroprotection research programs.
Common research applications: neurotrophin expression studies, GABAergic and enkephalinase models, and cognitive performance paradigms in laboratory animals.
Blend composition (per vial): Selank 10mg + Semax 10mg – 20mg total peptide content.
Specifications
| Compound | Selank + Semax blend |
|---|---|
| Quantity | Selank 10mg + Semax 10mg (20mg total) per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is in this blend?
Each vial contains Selank 10mg and Semax 10mg as a combined lyophilized powder, 20mg total peptide content.
What are Selank and Semax studied for?
Selank research has examined GABAergic signaling and enkephalin degradation; Semax research has examined BDNF expression and cognitive paradigms. All work is laboratory research only.
Why are they blended?
The two peptides are frequently studied together in cognitive research programs, and a single vial with a fixed 1:1 ratio simplifies laboratory workflows.
For laboratory research use only. This product is not for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
Reviews
There are no reviews yet.